New Cholesterol Guidelines Emphasize Lowering LDL Levels for Heart Health

Studies Warn Against Minimally Invasive Surgery for Cervical Cancer
November 19, 2018
Rates of Multiple Sclerosis Relapses Vary Before, During, and After Pregnancy
November 19, 2018
Show all

New Cholesterol Guidelines Emphasize Lowering LDL Levels for Heart Health

High cholesterol is a common health risk for many adults and scientists are now finding better ways to treat it.

One out of every three American adults has high cholesterol, which raises their risk of heart disease – the No. 1 cause of death in the U.S. – and stroke.

How doctors go about caring for patients with high cholesterol is influenced by a set of guidelines published and updated periodically by the American College of Cardiology and American Heart Association.

New updates just made to those guidelines represent “a significant improvement” over the last updates made to them in 2013, says Steven Nissen, MD, the Chairman of Cardiovascular Medicine at Cleveland Clinic.

The latest guidelines maintain an emphasis on the importance of a healthy lifestyle – including a nutrient-dense diet and regular exercise – as the first step in preventing heart disease and stroke. They also emphasize that treatment decisions about high cholesterol should be a collaboration between doctors and patients, Dr. Nissen says.

But they also address some concerns that doctors had after the last set of guidelines was published in 2013, as well as some additional improvements.

A flaw in the risk calculator

One of the most-criticized aspects of the 2013 guidelines was the introduction of a “risk calculator” to help physicians assess a person’s 10-year risk of heart disease and whether they should be treated with statin drugs.

Some doctors raised alarm about the calculator, saying it could over- or underestimate a person’s individual risk because it was designed based on population-level data. The calculator didn’t, for example, take into account an individual’s family history, which doctors have long known is an important risk factor for heart disease, Dr. Nissen says.

The new version of the guidelines encourages physicians to base treatment recommendations not just on the calculator but also on factors including family history and whether someone is of high-risk ethnicity.

They also recommend that patients discuss certain health conditions that could affect their risk or treatment with their doctor, such as metabolic syndrome, chronic kidney disease, inflammatory conditions, premature menopause or pre-eclampsia, or high lipid biomarkers.

A focus on reducing LDL target levels

Another notable change, according to Dr. Nissen, is that the new guidelines bring back the notion that lower levels of low-density lipoprotein (LDL) cholesterol are desirable and should be targeted and measured.

LDL is a major cause of coronary artery disease and is the culprit behind most troublesome cholesterol buildup in the arteries. But the 2013 recommendations eliminated target LDL values for patients requiring treatment. They essentially recommended that patients either take statins or not based on that person’s level of risk as determined by the calculator, rather than by LDL levels.

The new guidelines suggest that people with LDL levels above 70 who are at high risk for heart disease should consider cholesterol-lowering therapy.

“They are bringing back these LDL thresholds for treatment,” Dr. Nissen says.

They also recommend monitoring a patient’s LDL values shortly after starting a new treatment, and then periodically thereafter. “I think this is prudent – it lets patients know how they’re doing, it emphasizes compliance and it ensures that people will have lower levels of cholesterol,” Dr. Nissen says.


Read on: [wp_colorbox_media url=”” type=”iframe” hyperlink=”New Cholesterol Guidelines Emphasize Lowering LDL Levels for Heart Health”]

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.